作者 | 张宇洁 编辑 | 彭孝秋 硬氪获悉，近日，深圳好博窗控技术股份有限公司（以下简称"好博窗控"）撤回了深交所主板IPO申请，此次IPO耗时两年，历经两轮问询。原计划融资 5.7亿，用于智能系统产业园建设。 好博窗控成立于2004年，主要为不同区域的居民提供门窗五金解决方案。门窗控制装置属于门窗配件，控制门窗的"启闭停"，主要由铰链、合页、角传动 器等五金组件组成。相比于橱柜、卫浴、厨房五金而言，门窗五金对于材料的耐用度、强度、设计结构要求更高。 （图源/官网） 门窗五金行业的上游主要为锌合金、铝合金、不锈钢等金属制品生产企业，中游企业负责产品研发设计和加工制造，下游客户主要为门窗厂、装修公司、 房地产公司、建材贸易商等，产品主要用于新建、存量住宅。 （图源/招股书） 公司主要产品包括三部分：门窗控制装置、智能化门窗控制产品和STORO系统门窗解决方案。其中，门窗控制装置销售收入占各期主营业务收入的九 成；智能化门窗控制产品是未来发展方向；STORO系统门窗解决方案收入占比较少。 | | | | | | | | 早\L: 月几 | | | --- | --- | --- | --- | --- | -- ...

Group 1 - The core point of the article highlights that there are no new IPO applications this week, while the third IPO of the year has been accepted on the Sci-Tech Innovation Board [1][2][4] - Ningbo Jianxin Superconducting Technology Co., Ltd. (referred to as "Jianxin Superconducting") has had its IPO application accepted, aiming to raise 865 million yuan [2][3] - Jianxin Superconducting specializes in the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, with its products accounting for approximately 50% of the cost of MRI equipment [3][4] Group 2 - Jianxin Superconducting is one of the earliest manufacturers in China to produce high-field superconducting magnets at scale, breaking the long-standing monopoly of foreign companies [3] - The company has established partnerships with well-known MRI equipment manufacturers, including Fujifilm, GE Healthcare, and others [3] - In terms of market share, Jianxin Superconducting ranks fifth globally and second domestically in the superconducting magnet sector, with a 4.2% global market share [3] Group 3 - The company plans to use the funds raised from the IPO for projects including the annual production of 600 sets of helium-free superconducting magnets and technological upgrades for high-field medical superconducting magnets [4] - The article notes that Jianxin Superconducting's acceptance for IPO reflects the ongoing effects of the "Eight Articles of the Sci-Tech Innovation Board" policy [4] - In total, 13 IPOs have been accepted this year across the Shanghai, Shenzhen, and Beijing exchanges, with three on the Shanghai exchange, all from the Sci-Tech Innovation Board [4]

Group 1 - The core viewpoint of the news is the acceptance of the IPO application of Ningbo Jianxin Superconducting Technology Co., Ltd. on the Sci-Tech Innovation Board, marking it as the third company to be accepted for IPO this year [1][2]. - Jianxin Superconducting focuses on the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, with its main products including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI equipment [2][3]. - The company has established partnerships with well-known MRI equipment manufacturers such as Fujifilm, GE Healthcare, and others, positioning itself as a leading independent supplier of superconducting magnets globally [2][3]. Group 2 - Jianxin Superconducting's projected revenues for 2022 to 2024 are 359 million yuan, 451 million yuan, and 425 million yuan, respectively, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan [3]. - The IPO aims to raise 865 million yuan for projects including the annual production of 600 sets of helium-free superconducting magnets and the technological transformation of high-field medical superconducting magnets [3]. - The acceptance of Jianxin Superconducting's IPO application highlights the ongoing effects of the "Eight Policies of the Sci-Tech Innovation Board," with a total of 13 IPOs accepted this year across various exchanges [3][8].